Literature DB >> 10093990

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

A A Weber, K C Zimmermann, J Meyer-Kirchrath, K Schrör.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10093990     DOI： 10.1016/S0140-6736(99)00498-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia.

Authors:  Maribeth Friend; Ivana Vucenik; Michael Miller
Journal:  BMJ       Date:  2003-01-11

2.  The variability of platelet response to aspirin and clopidogrel: revisiting the Caprie, Cure, Credo, and Match trials.

Authors:  Robert I Myers
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

Review 3.  Obesity and Altered Aspirin Pharmacology.

Authors:  Nicholas B Norgard
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

Review 4.  Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk.

Authors:  Francesco Cipollone; Maria Luigia Fazia
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

Review 5.  Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions.

Authors:  Anetta Undas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

Review 6.  A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes.

Authors:  Burak Pamukcu
Journal:  J Thromb Thrombolysis       Date:  2006-12-22       Impact factor: 2.300

7.  A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets.

Authors:  Qianghua Hu; Min Soon Cho; Perumal Thiagarajan; Fleur M Aung; Anil K Sood; Vahid Afshar-Kharghan
Journal:  Platelets       Date:  2016-08-18       Impact factor: 3.862

8.  Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets.

Authors:  Bianca Rocca; Paola Secchiero; Giovanni Ciabattoni; Franco O Ranelletti; Lucia Catani; Lia Guidotti; Elisabetta Melloni; Nicola Maggiano; Giorgio Zauli; Carlo Patrono
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 9.  Monitoring aspirin and clopidogrel response: testing controversies and recommendations.

Authors:  Athanasios Karathanos; Tobias Geisler
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

10.  Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.

Authors:  Jeffrey A Martinson; Alejandro Roman-Gonzalez; Allan R Tenorio; Carlos J Montoya; Carolyne N Gichinga; Maria T Rugeles; Mark Tomai; Arthur M Krieg; Smita Ghanekar; Linda L Baum; Alan L Landay
Journal:  Cell Immunol       Date:  2008-03-10       Impact factor: 4.868
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.